These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28067167)

  • 1. 6-benzothiazolyl ureas, thioureas and guanidines are potent inhibitors of ABAD/17β-HSD10 and potential drugs for Alzheimer's disease treatment: Design, synthesis and in vitro evaluation.
    Benek O; Hroch L; Aitken L; Dolezal R; Guest P; Benkova M; Soukup O; Musil K; Kuca K; Smith TK; Gunn-Moore F; Musilek K
    Med Chem; 2017 Jan; ():. PubMed ID: 28067167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer's disease treatment.
    Hroch L; Benek O; Guest P; Aitken L; Soukup O; Janockova J; Musil K; Dohnal V; Dolezal R; Kuca K; Smith TK; Gunn-Moore F; Musilek K
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3675-8. PubMed ID: 27287370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Benzothiazole-based Ureas as 17β-HSD10 Inhibitors, A Potential Alzheimer's Disease Treatment.
    Aitken L; Benek O; McKelvie BE; Hughes RE; Hroch L; Schmidt M; Major LL; Vinklarova L; Kuca K; Smith TK; Musilek K; Gunn-Moore FJ
    Molecules; 2019 Jul; 24(15):. PubMed ID: 31362457
    [No Abstract]   [Full Text] [Related]  

  • 4. Infantile Neurodegeneration Results from Mutants of 17β-Hydroxysteroid Dehydrogenase Type 10 Rather Than Aβ-Binding Alcohol Dehydrogenase.
    He XY; Dobkin C; Brown WT; Yang SY
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer's disease treatment.
    Hroch L; Guest P; Benek O; Soukup O; Janockova J; Dolezal R; Kuca K; Aitken L; Smith TK; Gunn-Moore F; Zala D; Ramsay RR; Musilek K
    Bioorg Med Chem; 2017 Feb; 25(3):1143-1152. PubMed ID: 28082069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of submicromolar 17β-HSD10 inhibitors and their in vitro and in vivo evaluation.
    Benek O; Vaskova M; Miskerikova M; Schmidt M; Andrys R; Rotterova A; Skarka A; Hatlapatkova J; Karasova JZ; Medvecky M; Hroch L; Vinklarova L; Fisar Z; Hroudova J; Handl J; Capek J; Rousar T; Kobrlova T; Dolezal R; Soukup O; Aitken L; Gunn-Moore F; Musilek K
    Eur J Med Chem; 2023 Oct; 258():115593. PubMed ID: 37390508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Hydroxyacyl-CoA and Alcohol Dehydrogenase Activities of Mitochondrial Type 10 17β-Hydroxysteroid Dehydrogenase in Neurodegeneration Study.
    He XY; Dobkin C; Brown WT; Yang SY
    J Alzheimers Dis; 2022; 88(4):1487-1497. PubMed ID: 35786658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of Type 10 17β-Hydroxysteroid Dehydrogenase in the Pathogenesis of Infantile Neurodegeneration and Alzheimer's Disease.
    He XY; Frackowiak J; Dobkin C; Brown WT; Yang SY
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomolar Benzothiazole-Based Inhibitors of 17β-HSD10 with Cellular Bioactivity.
    Hanzlova M; Miskerikova MS; Rotterova A; Chalupova K; Jurkova K; Hamsikova M; Andrys R; Haleckova A; Svobodova J; Schmidt M; Benek O; Musilek K
    ACS Med Chem Lett; 2023 Dec; 14(12):1724-1732. PubMed ID: 38116418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzothiazolyl Ureas are Low Micromolar and Uncompetitive Inhibitors of 17β-HSD10 with Implications to Alzheimer's Disease Treatment.
    Schmidt M; Benek O; Vinklarova L; Hrabinova M; Zemanova L; Chribek M; Kralova V; Hroch L; Dolezal R; Lycka A; Prchal L; Jun D; Aitken L; Gunn-Moore F; Kuca K; Musilek K
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologically relevant fluorescent assay for identification of 17β-hydroxysteroid dehydrogenase type 10 inhibitors.
    Schmidt M; Vaskova M; Rotterova A; Fiandova P; Miskerikova M; Zemanova L; Benek O; Musilek K
    J Neurochem; 2023 Oct; 167(2):154-167. PubMed ID: 37458164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of 17β-hydroxysteroid dehydrogenase type 10 in neurodegenerative disorders.
    Yang SY; He XY; Isaacs C; Dobkin C; Miller D; Philipp M
    J Steroid Biochem Mol Biol; 2014 Sep; 143():460-72. PubMed ID: 25007702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of Mitochondrial 17β-Hydroxysteroid Dehydrogenase Type 10 in Alzheimer's Disease.
    He XY; Isaacs C; Yang SY
    J Alzheimers Dis; 2018; 62(2):665-673. PubMed ID: 29480196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of 17β-Hydroxysteroid Dehydrogenase Type 10 and Cyclophilin D in Alzheimer's Disease.
    Kristofikova Z; Springer T; Gedeonova E; Hofmannova A; Ricny J; Hromadkova L; Vyhnalek M; Laczo J; Nikolai T; Hort J; Petrasek T; Stuchlik A; Vales K; Klaschka J; Homola J
    Neurochem Res; 2020 Apr; 45(4):915-927. PubMed ID: 31997103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evolutionary genomics of the HADH2 gene encoding Abeta-binding alcohol dehydrogenase/17beta-hydroxysteroid dehydrogenase type 10 (ABAD/HSD10).
    Marques AT; Antunes A; Fernandes PA; Ramos MJ
    BMC Genomics; 2006 Aug; 7():202. PubMed ID: 16899120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Assay Development and HTS of Small-Molecule Human ABAD/17β-HSD10 Inhibitors as Therapeutics in Alzheimer's Disease.
    Aitken L; Baillie G; Pannifer A; Morrison A; Jones PS; Smith TK; McElroy SP; Gunn-Moore FJ
    SLAS Discov; 2017 Jul; 22(6):676-685. PubMed ID: 28314118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-3 Steroidal Hemiesters as Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 10.
    Hanzlova M; Slavikova B; Morozovova M; Musilek K; Rotterova A; Zemanová L; Kudova E
    ACS Omega; 2024 Mar; 9(10):12116-12124. PubMed ID: 38496976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of human ABAD/HSD10 with a bound inhibitor: implications for design of Alzheimer's disease therapeutics.
    Kissinger CR; Rejto PA; Pelletier LA; Thomson JA; Showalter RE; Abreo MA; Agree CS; Margosiak S; Meng JJ; Aust RM; Vanderpool D; Li B; Tempczyk-Russell A; Villafranca JE
    J Mol Biol; 2004 Sep; 342(3):943-52. PubMed ID: 15342248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of 17β-Hydroxysteroid Dehydrogenase Type 10 in Cerebrospinal Fluid of People with Mild Cognitive Impairment and Various Types of Dementias.
    Kristofikova Z; Ricny J; Vyhnalek M; Hort J; Laczo J; Sirova J; Klaschka J; Ripova D
    J Alzheimers Dis; 2015; 48(1):105-14. PubMed ID: 26401932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of steroidal derivatives inhibiting the transformations of allopregnanolone and estradiol by 17β-hydroxysteroid dehydrogenase type 10.
    Boutin S; Roy J; Maltais R; Alata W; Calon F; Poirier D
    Bioorg Med Chem Lett; 2018 Dec; 28(22):3554-3559. PubMed ID: 30297283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.